These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22892605)

  • 21. Febrile Neutropenia in Patients with Solid Tumors Undergoing Intravenous Chemotherapy.
    Moreira-Pinto J; Leão I; Palmela C; Branco F; Godinho J; Simões P; Leal-Costa L; Lopes F; Faria A; Casa-Nova M; Escária A; Costa F; Galvão I; Teixeira J; Passos-Coelho JL
    Oncol Res Treat; 2020; 43(11):605-612. PubMed ID: 32818937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk predictors for adverse outcome in pediatric febrile neutropenia: Single center experience from a low and middle-income country.
    Prasad M; Chinnaswamy G; Arora B; Vora T; Hawaldar R; Banavali S
    Indian J Cancer; 2014; 51(4):432-7. PubMed ID: 26842150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Febrile neutropenia in the tropics: a description of clinical and microbiological findings and their impact on inappropriate therapy currently used at an oncological reference center in Colombia.
    Cortés JA; Cuervo S; Gómez CA; Bermúdez D; Martínez T; Arroyo P
    Biomedica; 2013; 33(1):70-7. PubMed ID: 23715309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is parenteral chemotherapy safe in rural hospitals? A prospective audit of neutropenic fever in Albany Hospital, a regional West Australian cancer centre.
    Kennedy K; Auret K
    Intern Med J; 2017 Feb; 47(2):177-182. PubMed ID: 27753283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy.
    Cosler LE; Sivasubramaniam V; Agboola O; Crawford J; Dale D; Lyman GH
    Value Health; 2005; 8(1):47-52. PubMed ID: 15841893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
    van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006247. PubMed ID: 27107610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
    Mayordomo JI; López A; Viñolas N; Castellanos J; Pernas S; Domingo Alonso J; Frau A; Layola M; Antonio Gasquet J; Sánchez J;
    Curr Med Res Opin; 2009 Oct; 25(10):2533-42. PubMed ID: 19722781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
    Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
    Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The disease and economic burden of neutropenic fever in adult patients in Australian cancer treatment centres 2008: analysis of the Victorian Admitted Episodes Dataset.
    Lingaratnam S; Thursky KA; Slavin MA; Kirsa SW; Bennett CA; Worth LJ
    Intern Med J; 2011 Jan; 41(1b):121-9. PubMed ID: 21272176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness analysis of the 2018 ASCO/IDSA guideline for outpatient management of fever and neutropenia in adults treated for malignancy.
    Hwang S; Kwon KT; Kim Y; Bae S; Chang HH; Kim SW; Yoo SS; Nam SY; Baek JH
    Sci Rep; 2021 Sep; 11(1):9048. PubMed ID: 34526516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia.
    Rosa RG; Goldani LZ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3799-803. PubMed ID: 24752269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
    Borget I; Antoun S; Chachaty E; Gachot B; Alibay A; Di Palma M; Merad M
    Bull Cancer; 2014 Oct; 101(10):925-31. PubMed ID: 25373692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia.
    Petrilli A; Altruda Carlesse F; Alberto Pires Pereira C
    Pediatr Blood Cancer; 2007 Oct; 49(5):682-6. PubMed ID: 17253640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fever and neutropenia outcomes and areas for intervention: A report from SUCCOUR - Supportive Care for Children with Cancer in Africa.
    Israels T; Afungchwi GM; Klootwijk L; Njuguna F; Hesseling P; Kouya F; Paintsil V; Landman L; Chitsike I; Chagaluka G; Sung L; Molyneux E
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29224. PubMed ID: 34245212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost of the inpatient management of febrile neutropenia in cancer patients--a micro-costing study in the Irish healthcare setting.
    O'Brien C; Fogarty E; Walsh C; Dempsey O; Barry M; Kennedy MJ; McCullagh L
    Eur J Cancer Care (Engl); 2015; 24(1):125-32. PubMed ID: 24472035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective audit of treatment of paediatric febrile neutropenia in Australasia.
    Chamberlain JD; Smibert E; Skeen J; Alvaro F
    J Paediatr Child Health; 2005 Nov; 41(11):598-603. PubMed ID: 16398846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early hospital discharge of children with fever and neutropenia: a prospective study.
    Wacker P; Halperin DS; Wyss M; Humbert J
    J Pediatr Hematol Oncol; 1997; 19(3):208-11. PubMed ID: 9201142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort.
    Van de Wyngaert Z; Berthon C; Debarri H; Bories C; Bonnet S; Nudel M; Carpentier B; Legrand C; Barbieux S; Chauvet P; Simonnet A; Willaume A; Bossard JB; Renaud L; Wattebled KJ; Escure G; Branche N; Arib I; Titecat M; Quesnel B; Alfandari S
    Int J Antimicrob Agents; 2019 Jun; 53(6):781-788. PubMed ID: 30831232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapy-induced febrile neutropenia: About 186 episodes. Clinical, microbiological and therapeutic characteristics].
    Masmoudi S; Khanfir A; Maalej-Mezghan S; Hammami A; Frikha M
    Tunis Med; 2015 Apr; 93(4):217-22. PubMed ID: 26375737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.